Increased CHIP Prevalence Amongst People Living with HIV.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
07 Nov 2020
Historique:
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 12 11 2020
Statut: epublish

Résumé

People living with human immunodeficiency virus (PLWH) have significantly increased risk for cardiovascular disease in part due to inflammation and immune dysregulation. Clonal hematopoiesis of indeterminate potential (CHIP), the age-related acquisition and expansion of hematopoietic stem cells due to leukemogenic driver mutations, increases risk for both hematologic malignancy and coronary artery disease (CAD). Since increased inflammation is hypothesized to be both a cause and consequence of CHIP, we hypothesized that PLWH have a greater prevalence of CHIP. We searched for CHIP in multi-ethnic cases from the Swiss HIV Cohort Study (SHCS, n=600) and controls from the Atherosclerosis Risk in the Communities study (ARIC, n=8,111) from blood DNA-derived exome sequences. We observed that HIV is associated with increased CHIP prevalence, both in the whole study population and in a subset of 230 cases and 1002 matched controls selected by propensity matching to control for demographic imbalances (SHCS 7%, ARIC 3%, p=0.005). Additionally, unlike in ARIC, ASXL1 was the most commonly implicated mutated CHIP gene. We propose that CHIP may be one mechanism through which PLWH are at increased risk for CAD. Larger prospective studies should evaluate the hypothesis that CHIP contributes to the excess cardiovascular risk in PLWH.

Identifiants

pubmed: 33173934
doi: 10.1101/2020.11.06.20225607
pmc: PMC7654930
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NHLBI NIH HHS
ID : RC2 HL102419
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK040561
Pays : United States
Organisme : NIH HHS
ID : DP5 OD029586
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151283
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148565
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG003273
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134892
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL086694
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL123336
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148050
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Science. 2020 Mar 27;367(6485):1449-1454
pubmed: 32217721
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
J Infect Dis. 2017 Nov 27;216(9):1063-1069
pubmed: 28968755
Nat Rev Cardiol. 2014 Dec;11(12):728-41
pubmed: 25331088
Science. 2017 Feb 24;355(6327):842-847
pubmed: 28104796
Nat Genet. 2015 Jun;47(6):640-2
pubmed: 25915599
N Engl J Med. 2017 Jul 13;377(2):111-121
pubmed: 28636844
Circulation. 2020 Jan 14;141(2):124-131
pubmed: 31707836
Int J Epidemiol. 2010 Oct;39(5):1179-89
pubmed: 19948780
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Nature. 2020 Oct;586(7831):763-768
pubmed: 33057201
Leukemia. 2020 Oct;34(10):2660-2672
pubmed: 32518416
Leuk Lymphoma. 2019 Dec;60(14):3529-3535
pubmed: 31282240

Auteurs

Alexander G Bick (AG)

Division of Genetic Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.

Konstantin Popadin (K)

School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Christian W Thorball (CW)

School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Md Mesbah Uddin (MM)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Markella Zanni (M)

Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Bing Yu (B)

Human Genetics Center, University of Texas Health Science Center, Houston, TX, USA Baylor College of Medicine, Houston, Texas, USA.

Matthias Cavassini (M)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Andri Rauch (A)

Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland.

Philip Tarr (P)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Patrick Schmid (P)

Division of Infectious Diseases, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.

Enos Bernasconi (E)

Division of Infectious Diseases, Regional Hospital of Lugano, Lugano, Switzerland.

Huldrych F Günthard (HF)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Peter Libby (P)

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Eric Boerwinkle (E)

Human Genetics Center, University of Texas Health Science Center, Houston, TX, USA Baylor College of Medicine, Houston, Texas, USA.

Paul J McLaren (PJ)

JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.

Christie M Ballantyne (CM)

Department of Medicine, Baylor College of Medicine, Houston, TX.

Steven Grinspoon (S)

Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Pradeep Natarajan (P)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.

Jacques Fellay (J)

School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Classifications MeSH